Atıf Formatları
Applying Quality by Design Principles in the Development and Preparation of a New Radiopharmaceutical: Technetium-99m-Imatinib Mesylate.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

E. Gundogdu Et Al. , "Applying Quality by Design Principles in the Development and Preparation of a New Radiopharmaceutical: Technetium-99m-Imatinib Mesylate.," ACS omega , vol.5, pp.5297-5305, 2020

Gundogdu, E. Et Al. 2020. Applying Quality by Design Principles in the Development and Preparation of a New Radiopharmaceutical: Technetium-99m-Imatinib Mesylate.. ACS omega , vol.5 , 5297-5305.

Gundogdu, E., Demir, E., Özgenç, E., Yeğen, G., & Aksu, B., (2020). Applying Quality by Design Principles in the Development and Preparation of a New Radiopharmaceutical: Technetium-99m-Imatinib Mesylate.. ACS omega , vol.5, 5297-5305.

Gundogdu, EVREN Et Al. "Applying Quality by Design Principles in the Development and Preparation of a New Radiopharmaceutical: Technetium-99m-Imatinib Mesylate.," ACS omega , vol.5, 5297-5305, 2020

Gundogdu, EVREN A. Et Al. "Applying Quality by Design Principles in the Development and Preparation of a New Radiopharmaceutical: Technetium-99m-Imatinib Mesylate.." ACS omega , vol.5, pp.5297-5305, 2020

Gundogdu, E. Et Al. (2020) . "Applying Quality by Design Principles in the Development and Preparation of a New Radiopharmaceutical: Technetium-99m-Imatinib Mesylate.." ACS omega , vol.5, pp.5297-5305.

@article{article, author={EVREN ATLIHAN GÜNDOĞDU Et Al. }, title={Applying Quality by Design Principles in the Development and Preparation of a New Radiopharmaceutical: Technetium-99m-Imatinib Mesylate.}, journal={ACS omega}, year=2020, pages={5297-5305} }